İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2024 · article

Medical and advanced heart failure therapies in Türkiye

YÖKSİS OpenAlex Açık erişim · diamond TR Index
Yıl2024
Atıf1OpenAlex
Yüzdelik%64,6
FWCI0,271,00 = dünya ortalaması
Scopus (SJR)Q3
WoS (JCR)Q3

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıTurkish Journal of Medical Sciences
  • Katalog eşleşmesi (ISSN)Turkish Journal of Medical Sciences
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

Background/aim: Effective management of heart failure involves evidence-based use of multiple medications and their combinations. Furthermore, dosage escalation of the recommended medications is advised. In cases of advanced heart failure, long-term mechanical assistance devices or heart transplantation surgery may be necessary. Socio-economic disparities create unequal opportunities for people to access these treatments.The study aimed to analyze and compare medical and advanced heart failure treatments recommended by guidelines across various regions in Türkiye. Materials and methods: About 85 million citizens medical treatment records were utilized between January 1, 2016, and December 31, 2022. Medical and heart replacement treatment opportunities for heart failure in Türkiye were evaluated in the general population and across different geographical regions. Results: According to this study, beta-blockers were the most commonly prescribed medication for heart failure in Türkiye. This was followed by angiotensin-converting enzyme inhibitors at 44% and mineralocorticoid receptor antagonists at 38.9%. However, only 0.6% of patients used angiotensin receptor blocker-neprilysin inhibitors. Despite the high incidence of diabetes mellitus among heart failure patients, only 11% used sodium-glucose cotransporter two inhibitors. The study also found that using an implantable cardioverter defibrillator (ICD) was 0.8%, and cardiac resynchronization therapy (CRT) was 0.3% among all intracardiac device treatments. Heart replacement therapies, cardiac transplantation surgery, and long-term left ventricle-assisted device (LVAD) surgery had very low rates. Conclusion: The use of guideline-directed medical therapy is not optimal in Türkiye and varies across different geographical regions. It is a fact that heart transplant or LVAD surgery, CRT, and ICD implantation rates in Türkiye are significantly lower than those in developed countries, regardless of geographical region.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

1atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yazarlar

14
  1. SANEM NALBANTGİL 1
  2. EMRE DEMİR 2
  3. AHMET ÇELİK 3
  4. İNCİ TUĞÇE ÇÖLLÜOĞLU 4
  5. NAİM ATA 5
  6. MEHMET BİRHAN YILMAZ 6
  7. ANIL ŞAHİN ÇANAKKALE ONSEKİZ MART ÜNİVERSİTESİ 7
  8. DİLEK URAL 8
  9. MUSTAFA MAHİR ÜLGÜ 9
  10. EMİNE ARZU KANIK AKICIER 10
  11. LALE DİNÇ ASARCIKLI 11
  12. YÜKSEL ÇAVUŞOĞLU 12
  13. SELDA MURAT 13
  14. ŞUAYIP BİRİNCİ 14